Bioventus gets FDA clearance for bone cutting tool

Bioventus’ Nexus BoneScalpel Access handpiece was cleared by the FDA.

Advertisement

The handpiece is designed for bone removal during minimally invasive surgery and to provide maximum visualization, according to a Dec. 20 news release. BoneScalpel Access is powered by the company’s ultrasonic surgical aspirator system, which has been commercialized in the U.S., Canada, Europe and Australia.

Bioventus’ BoneScalpel Access is expected to launch in 2022.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.